Propensity score weighted multi‐source exchangeability models for incorporating external control data in randomized clinical trials
Statistics in Medicine · 2024
DOI: 10.1002/sim.10158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, 2024. Verfasst von Wei Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut. Hauptthemen laut MEDLINE: Propensity Score, Randomized Controlled Trials as Topic, Models, Statistical, Computer Simulation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: NCI NIH HHS, NIDCR NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Among clinical trialists, there has been a growing interest in using external data to improve decision‐making and accelerate drug development in randomized clinical trials (RCTs). Here we propose a novel approach that combines the propensity score weighting (PW) and the multi‐source exchangeability modelling (MEM) approaches to augment the control arm of a RCT in the rare disease setting. First, propensity score weighting is used to construct weighted external controls that have similar observed pre‐treatment characteristics as the current trial population. Next, the MEM approach evaluates the similarity in outcome distributions between the weighted external controls and the concurrent control arm. The amount of external data we borrow is determined by the similarities in pretreatment characteristics and outcome distributions. The proposed approach can be applied to binary, continuous and count data. We evaluate the performance of the proposed PW‐MEM method and several competing approaches based on simulation and re‐sampling studies. Our results show that the PW‐MEM approach improves the precision of treatment effect estimates while reducing the biases associated with borrowing data from external sources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut.
- Global Biometrics & Data Management, Pfizer Inc, New York, New York, USA.
ORCID-Profile: Wei Wei, Satrajit Roychoudhury
Förderung
- NCI NIH HHS
- NIDCR NIH HHS
- National Cancer Institute
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Wei, W., Zhang, Y., Roychoudhury, S., & Alzheimer's Disease Neuroimaging Initiative (2024). Propensity score weighted multi‐source exchangeability models for incorporating external control data in randomized clinical trials. Statistics in Medicine. https://doi.org/10.1002/sim.10158
Vancouver
Wei W, Zhang Y, Roychoudhury S, Alzheimer's Disease Neuroimaging Initiative. Propensity score weighted multi‐source exchangeability models for incorporating external control data in randomized clinical trials. Statistics in Medicine. 2024. doi:10.1002/sim.10158
BibTeX
@article{Wei2024,
author = {Wei, Wei and Zhang, Yunxuan and Roychoudhury, Satrajit and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Propensity score weighted multi‐source exchangeability models for incorporating external control data in randomized clinical trials},
journal = {Statistics in Medicine},
year = {2024},
doi = {10.1002/sim.10158}
}
EUVIMED